会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Library of compounds comprising pyrrolobenzodiazepine moieties
    • 包含吡咯并苯并二氮杂部分的化合物文库
    • US07704924B2
    • 2010-04-27
    • US10602521
    • 2003-06-24
    • David Edwin ThurstonPhilip Wilson Howard
    • David Edwin ThurstonPhilip Wilson Howard
    • C40B40/10
    • C07D487/04Y02P20/55
    • A compound of formula (IV): O is a solid support; L is a linking group or a single bond; X′ is selected from CO, NH, S, or O; A is O, S, NH, or a single bond; R2 and R3 are independently selected from: H, R, OH, OR, ═O, ═CH—R, ═CH2, CH2—CO2R, CH2—CO2H, CH2—SO2R, O—SO2R, CO2R, COR, CN and there is optionally a double bond between C1 and C2 or C2 and C3; R6, R7, and R9 are independently selected from H, R, OH, OR, halo, nitro, amino, Me3Sn; R11 is either H or R; Q is S, O or NH; R10 is a nitrogen protecting group; and Y is a divalent group such that HY═R, and other related compounds and collections of compounds.
    • 式(Ⅳ)化合物:O是固体载体; L是连接基团或单键; X'选自CO,NH,S或O; A是O,S,NH或单键; R 2和R 3独立地选自:H,R,OH,OR,= O,= CH-R,= CH 2,CH 2 -CO 2 R,CH 2 -CO 2 H,CH 2 -SO 2 R,O-SO 2 R,CO 2 R,COR, 可选地是C1和C2或C2和C3之间的双键; R 6,R 7和R 9独立地选自H,R,OH,OR,卤素,硝基,氨基,Me 3 Sn; R11是H或R; Q是S,O或NH; R10为氮保护基; 并且Y是二价基团,使得HY = R,以及其它相关化合物和化合物的集合。
    • 3. 发明授权
    • Pyrrolobenzodiazepines
    • 吡咯并苯并二氮杂卓
    • US07067511B2
    • 2006-06-27
    • US10021213
    • 2001-12-12
    • David Edwin ThurstonPhilip Wilson Howard
    • David Edwin ThurstonPhilip Wilson Howard
    • A61K31/55C07D487/00A61P35/00
    • C07D487/04
    • Compounds of the formulae Ia and Ib: wherein: A is CH2, or a single bond; R2 is selected from: R, OH, OR, CO2H, CO2R, COH, COR, SO2R, CN; R6, R7 and R9 are independently selected from H, R, OH, OR, halo, amino, NHR, nitro, Me3Sn; and R8 is selected from H, R, OH, OR, halo, amino, NHR, nitro, Me3Sn, where R is as defined above, or the compound is a dimer with each monomer being the same or different and being of formula Ia or Ib, where the R8 groups of the monomers form together a bridge having the formula —X—R′—X— linking the monomers, where R′ is an alkylene chain containing from 3 to 12 carbon atoms, which chain may be interrupted by one or more hetero-atoms and/or aromatic rings and may contain one or more carbon-carbon double or triple bonds, and each X is independently selected from O, S, or N; except that in a compound of formula Ia when A is a single bond, then R2 is not CH═CH(CONH2) or CH═CH(CONMe2). Other related compounds are also disclosed.
    • 式Ia和Ib的化合物:其中:A是CH 2或单键; R 2选自:R,OH,OR,CO 2 H,CO 2 R,COH,COR,SO 2 R,CN; R 6,R 7和R 9独立地选自H,R,OH,OR,卤素,氨基,NHR,硝基,Me 3 Sn; 和R 8选自H,R,OH,OR,卤素,氨基,NHR,硝基,Me 3 Sn,其中R如上所定义,或化合物 是每个单体相同或不同并且具有式Ia或Ib的二聚体,其中单体的R 8 C基团一起形成具有式-X-R'-X-连接的桥 单体,其中R'是含有3至12个碳原子的亚烷基链,该链可以被一个或多个杂原子和/或芳环中断,并且可以含有一个或多个碳 - 碳双键或三键,以及 每个X独立地选自O,S或N; 但是当A为单键时,在式Ia化合物中,R 2不为CH-CH(CONH 2 H)或CH-CH(CONH 2) 2 )。 还公开了其它相关化合物。
    • 4. 发明授权
    • Collections of compounds
    • 化合物的集合
    • US06747144B1
    • 2004-06-08
    • US09763813
    • 2001-02-26
    • David Edwin ThurstonPhilip Wilson Howard
    • David Edwin ThurstonPhilip Wilson Howard
    • C07D48704
    • C07D487/04
    • A compound of formula (I), wherein: R2 and R3 are independently selected from H, R, OH, OR, ═O, ═CH—R, ═CH2, CH2—CO2R, CH2—CO2H, CH2—SO2R, O—SO2R, CO2R, COR and CN, and there is optionally a double bond between C1 and C2 or C2 and C3; R6, R7, R8 and R9 are independently selected from H, R, OH, OR, halo, nitro, amino, Me3Sn; R11 is either H or R; Q is S, O or NH; L is a linking group, or a single bond; O is a solid support; or where one or more of R2, R3, R6, R7 and R8 are independently: H—(T)n—X—Y—A— where: X is CO, NH, S or O; T is a combinatorial unit; Y is a divalent group such that HY=R; A is O, S, NH, or a single bond and n is a positive integer
    • 式(I)化合物,其中:R2和R3独立地选自H,R,OH,OR,= O,= CH-R,= CH2,CH2-CO2R,CH2-CO2H,CH2 -SO2R ,O-SO 2 R,CO 2 R,COR和CN,并且任选地在C1和C2或C2和C3之间具有双键; R 6,R 7,R 8和R 9独立地选自H,R,OH,OR,卤素,硝基,氨基,Me 3 Sn; R11是H或R; Q是S,O或NH; L是连接基团或单键; O是坚实的支持; 或其中R 2,R 3,R 6,R 7和R 8中的一个或多个独立地为:H-(T)n -X-Y-A-其中:X为CO,NH,S或O; T是组合单元; Y是二价基团,使得HY = R; A是O,S,NH或单键,n是正整数
    • 7. 发明授权
    • Cyclopropylindole derivatives
    • 环丙基吲哚衍生物
    • US06909006B1
    • 2005-06-21
    • US10069202
    • 2000-02-22
    • David Edwin ThurstonPhilip Wilson Howard
    • David Edwin ThurstonPhilip Wilson Howard
    • A61P43/00C07B61/00C07D209/60C07D209/96C07K1/04
    • C07D209/96C07D209/60C07K1/047C40B40/00Y02P20/55
    • Compounds of formula (III) or (V), wherein is a solid support; L is a linking group or a single bond; T is a combinatorial unit; n is a positive integer, where if n is greater than 1, each T may be different: X is an electrophilic leaving group; Y is selected from NH-Prot, O-Prot, S-Prot, NO2, —NHOH. N3, NHR, NRR, N═NR, N(O)RR, NHSO2R, N═N═PhR, SR or SSR, where Prot represents a protecting group; A and B collectively represent a fused benzene or pyrrole ring (in either orientation), which is optionally substituted by up to respectively 4 or 2 groups independently selected from R, OH, OR, halo, nitro, amino, Me3Sn, CO2H, CO2R, R1 is a nitrogen protecting group, where if Y includes a protecting group, these protecting groups are orthogonal and R2 and R7 are independently selected from H, R, OH, OR, halo, nitro, amino, Me3Sn, and other related compounds and collections of compounds.
    • 式(III)或(V)的化合物,其中为固体载体; L是连接基团或单键; T是组合单元; n是正整数,其中如果n大于1,则每个T可以不同:X是亲电离去基团; Y选自NH-Prot,O-Prot,S-Prot,NO 2,-NHOH。 N,N,N,N,N,R,N-N-PhR,SR或SSR,其中Prot代表保护基; A和B共同表示稠合的苯或吡咯环(任一方向),其任选被至多独立地选自R,OH,OR,卤素,硝基,氨基,Me 3, 其中如果Y包括保护基团,则其中R 1,R 2,R 2,R 2,R 1,R 2, 这些保护基是正交的,R 2和R 7独立地选自H,R,OH,OR,卤素,硝基,氨基,Me 3, SUB> Sn和其他相关化合物和化合物的集合。
    • 8. 发明授权
    • Pyrrolobenzodiazepines
    • 吡咯并苯并二氮杂卓
    • US06562806B1
    • 2003-05-13
    • US09763814
    • 2001-02-26
    • David Edwin ThurstonPhilip Wilson Howard
    • David Edwin ThurstonPhilip Wilson Howard
    • A61K31555
    • C07D487/04Y02P20/55
    • A compound with formula (I) where R10 is a therapeutically removable nitrogen protecting group; R2 and R3 are independently selected from: H, R, OH, OR, ═O, ═CH—R, ═CH2, CH2—CO2R, CH2—CO2H, CH2—SO2R, O—SO2—R, CO2R, COR and CN; R6, R7 and R9 are independently selected from H, R, OH, OR, halo, amino, nitro, Me3Sn; X is S, O or NH; R11 is either H or R; and where there is optionally a double bond between C1 and C2 or C2 and C3; and R8 is selected from H, R, OH, OR, halo, amino, nitro, Me3Sn, or R7 and R8 together form a group —O—(CH2)p—O—, where p is 1 or 2. Such compounds may be used in methods of ADEPT, GDEPT, NPEPT or PDT.
    • 具有式(I)的化合物,其中R 10是治疗性除去的氮保护基; R2和R3独立地选自:H,R,OH,OR,= O,= CH-R,= CH2,CH2-CO2R,CH2-CO2H,CH2-SO2R,O-SO2-R,CO2R,COR和CN ; R 6,R 7和R 9独立地选自H,R,OH,OR,卤素,氨基,硝基,Me 3 Sn; X是S,O或NH; R11是H或R; 并且其中C1和C2或C2和C3之间任选具有双键; 并且R 8选自H,R,OH,OR,卤素,氨基,硝基,Me 3 Sn或R 7和R 8一起形成基团-O-(CH 2)p O-,其中p为1或2。 在ADEPT,GDEPT,NPEPT或PDT的方法中。